Skip to content
HBI
  • Our Company
    • Overview
    • Team
    • Collaborators
    • In Memoriam
  • Technology
    • Overview
    • The Vaccine Platform
      • Viral Hemorrhagic Fever Vaccines Pipeline
      • Emerging & Re-emerging Disease Vaccines
    • Medical Counter Measures
  • Proteins & Adjuvants
  • Newsroom
  • Contact
  • Cookie Policy
  • Privacy Policy
  • Terms of Use

Categorie: Press Releases

Hawaii Biotech and Uh School of Medicine on Track for Zika Vaccine

Hawaii Biotech Awarded $38.5 Million for Continued Development of Anti‐toxin Drug to Treat Anthrax in Humans

 

 

Hawaii Biotech to Develop Ebola Vaccine With the University of Hawai’i

Hawaii Biotech Awarded Grant to Develop Chikungunya Virus Vaccine

Hawaii Biotech Opens New State-of-the-art R&D Laboratories and Headquarters

HTDC Awards More Than $3 Million in Grants to Hawaii Companies

Soligenix Announces Presentation of Positive Preliminary Results of a Heat Stable Formulation of Hawaii Biotech Ebola Vaccine

Hirono, Ige, Public Health, and Emergency Response Experts Raise Awareness, Call for Funding to Fight Zika

Hawaii Biotech to Relocate to Dole Cannery

Hawaii Biotech Receives Contract to Develop Dengue Vaccine

Posts navigation

Older posts

  • Our Company
    • Overview
    • Team
    • Collaborators
    • In Memoriam
  • Technology
    • Overview
    • The Vaccine Platform
      • Viral Hemorrhagic Fever Vaccines Pipeline
      • Emerging & Re-emerging Disease Vaccines
    • Medical Counter Measures
  • Proteins & Adjuvants
  • Newsroom
  • Contact
  • Cookie Policy
  • Privacy Policy
  • Terms of Use

Cookie Policy   |   Privacy Policy   |   Terms of Use


Copyright © 2023 Hawaii Biotech Inc. All rights reserved.

Employee Email